Xiaofang Zhao

Ministry Of Education Key Laboratory On Signaling Regulation And Targeting Therapy Of Liver Cancer, Shanghai Key Laboratory Of Hepatobiliary Tumor Biology
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Single-cell landscape of the intrahepatic ecosystem in alcohol-related liver disease.

Single-cell landscape of the intrahepatic ecosystem in alcohol-related liver disease.

Journal: Clinical and translational medicine
Published: August 25, 2024

Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions.

Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions.

Journal: Cell reports. Medicine
Published: February 23, 2023

Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors.

Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 15, 2021

Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade.

Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade.

Journal: Frontiers in immunology
Published: October 25, 2019

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma.

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma.

Journal: NPJ precision oncology
Published: October 11, 2019

Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage.

Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: June 30, 2018

Reduction in activating transcription factor 4 promotes carbon tetrachloride and lipopolysaccharide/D‑galactosamine‑mediated liver injury in mice.

Reduction in activating transcription factor 4 promotes carbon tetrachloride and lipopolysaccharide/D‑galactosamine‑mediated liver injury in mice.

Journal: Molecular medicine reports
Published: November 30, 2017

Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt/mTOR-independent pathway.

Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt/mTOR-independent pathway.

Journal: Journal of cellular biochemistry
Published: September 29, 2017

c‑Myc promotes cholangiocarcinoma cells to overcome contact inhibition via the mTOR pathway.

c‑Myc promotes cholangiocarcinoma cells to overcome contact inhibition via the mTOR pathway.

Journal: Oncology reports
Published: March 19, 2017

Unfolded Protein Response Promotes Doxorubicin-Induced Nonsmall Cell Lung Cancer Cells Apoptosis via the mTOR Pathway Inhibition.

Unfolded Protein Response Promotes Doxorubicin-Induced Nonsmall Cell Lung Cancer Cells Apoptosis via the mTOR Pathway Inhibition.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: November 30, 2016

Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells.

Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells.

Journal: Oncotarget
Published: August 20, 2016

PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.

PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.

Journal: Autophagy
Published: April 24, 2015
Showing 1-12 of 14

Last Updated: 09/26/2026